Develop a vaccine to end CMV.
Research into a vaccine for CMV has been massively underfunded for years, causing huge delays in the search for an effective vaccine. Despite this, the prospect of an effective vaccine looks promising with nine manufacturers reporting in 2018 that they have vaccines at various stages of development.
With the accelerating pace of research, it is believed a vaccine may be available within 10 years. We recognise that it will take years for CMV to become controlled in a whole community once a successful vaccine becomes licensed; this is why we believe investment in this area should be accelerated now, to reduce the number of years that CMV drains funds from the NHS.